Literature DB >> 6469237

Structure and composition of microcalcifications in benign and malignant lesions of the breast: study by light microscopy, transmission and scanning electron microscopy, microprobe analysis, and X-ray diffraction.

L Frappart, M Boudeulle, J Boumendil, H C Lin, I Martinon, C Palayer, Y Mallet-Guy, D Raudrant, A Bremond, Y Rochet.   

Abstract

Microcalcifications previously located by radiography were extracted from 25 fresh specimens obtained from patients who had undergone tumorectomy or systematized mammary exeresis. Two principal types of microcalcifications were distinguished: Type I microcalcifications were amber in color and generally crystalline on scanning electron microscopy, with only one calcium peak on microprobe analysis; x-ray diffraction revealed that weddellite was involved. Type II microcalcifications were whitish, nonbirefringent under polarized light, and generally ovoid or fusiform, with two peaks, one calcium and the other phosphorus, on microprobe analysis; these microcalcifications were composed of calcium phosphate, the most characteristic form of which is hydroxyapatite, in the form of needles arranged in rosettes on transmission electron microscopy. Type I microcalcifications were observed in four of eight benign breast lesions, in two of three in situ lobular carcinomas, and in no intraductal adenocarcinomas or infiltrating carcinomas. Type II microcalcifications were present in all infiltrating carcinomas and intraductal adenocarcinomas; they were also found in benign lesions (four of eight) and even associated with type I microcalcifications in one in situ lobular carcinoma. There are, therefore, no "benign" or "malignant" microcalcifications; however, the presence of weddellite is a strong indication that a lesion is benign or, at most, an in situ lobular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6469237     DOI: 10.1016/s0046-8177(84)80150-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  36 in total

1.  Calcium oxalate (Weddellite) crystals within ductal carcinoma in situ.

Authors:  H M Martin; A C Bateman; J M Theaker
Journal:  J Clin Pathol       Date:  1999-12       Impact factor: 3.411

2.  Secretory pathway Ca2+ -ATPases promote in vitro microcalcifications in breast cancer cells.

Authors:  Donna Dang; Hari Prasad; Rajini Rao
Journal:  Mol Carcinog       Date:  2017-07-28       Impact factor: 4.784

3.  Calcium oxalate crystals (Weddellite) within the secretions of ductal carcinoma in situ--a rare phenomenon.

Authors:  N Singh; J M Theaker
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

4.  Correlative imaging reveals physiochemical heterogeneity of microcalcifications in human breast carcinomas.

Authors:  Jennie A M R Kunitake; Siyoung Choi; Kayla X Nguyen; Meredith M Lee; Frank He; Daniel Sudilovsky; Patrick G Morris; Maxine S Jochelson; Clifford A Hudis; David A Muller; Peter Fratzl; Claudia Fischbach; Admir Masic; Lara A Estroff
Journal:  J Struct Biol       Date:  2017-12-06       Impact factor: 2.867

5.  Different types of microcalcifications observed in breast pathology. Correlations with histopathological diagnosis and radiological examination of operative specimens.

Authors:  L Frappart; I Remy; H C Lin; A Bremond; D Raudrant; B Grousson; J L Vauzelle
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

6.  Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis.

Authors:  Ayse Corut; Abdurrahman Senyigit; Sibel Aylin Ugur; Sedat Altin; Ugur Ozcelik; Haluk Calisir; Zeki Yildirim; Ayhan Gocmen; Aslihan Tolun
Journal:  Am J Hum Genet       Date:  2006-08-29       Impact factor: 11.025

7.  Detection of breast cancer microcalcification using (99m)Tc-MDP SPECT or Osteosense 750EX FMT imaging.

Authors:  Dayo D Felix; John C Gore; Thomas E Yankeelov; Todd E Peterson; Stephanie Barnes; Jennifer Whisenant; Jared Weis; Sepideh Shoukouhi; John Virostko; Michael Nickels; J Oliver McIntyre; Melinda Sanders; Vandana Abramson; Mohammed N Tantawy
Journal:  Nucl Med Biol       Date:  2014-12-06       Impact factor: 2.408

8.  Bisphosphonate-functionalized gold nanoparticles for contrast-enhanced X-ray detection of breast microcalcifications.

Authors:  Lisa E Cole; Tracy Vargo-Gogola; Ryan K Roeder
Journal:  Biomaterials       Date:  2013-12-18       Impact factor: 12.479

9.  Osteotropic cancer diagnosis by an osteocalcin inspired molecular imaging mimetic.

Authors:  Jae Sam Lee; Ching-Hsuan Tung
Journal:  Biochim Biophys Acta       Date:  2013-05-17

Review 10.  A Molecular View of Pathological Microcalcification in Breast Cancer.

Authors:  Tanu Sharma; James A Radosevich; Geeta Pachori; Chandi C Mandal
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-01-15       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.